Studying how administration route and dose regulates antibody generation against LNPs for mRNA delivery with single-particle resolution

Following the recent approval of both siRNA- and mRNA-based therapeutics, nucleic acid therapies are considered a game changer in medicine. Their envisioned widespread use for many therapeutic applications with an array of cellular target sites means that various administration routes will be employ...

Descripción completa

Detalles Bibliográficos
Autores principales: Münter, Rasmus, Christensen, Esben, Andresen, Thomas L., Larsen, Jannik B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220314/
https://www.ncbi.nlm.nih.gov/pubmed/37251983
http://dx.doi.org/10.1016/j.omtm.2023.05.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220314/
https://www.ncbi.nlm.nih.gov/pubmed/37251983
http://dx.doi.org/10.1016/j.omtm.2023.05.008

Ejemplares similares